0000000001030692

AUTHOR

Margherita Nosadini

showing 2 related works from this author

Survey on treatments for primary headaches in 13 specialized juvenile Headache Centers: The first multicenter Italian study

2017

Abstract Aim The purpose of this retrospective multicenter study was to evaluate the use and the self-perceived efficacy and tolerability of pharmacological and non-pharmacological treatments in children and adolescents with primary headaches. Methods Study of a cohort of children and adolescents diagnosed with primary headache, consecutively referred to 13 juvenile Italian Headache Centers. An ad hoc questionnaire was used for clinical data collection. Results Among 706 patients with primary headaches included in the study, 637 cases with a single type of headache (migraine 76% – with and without aura in 10% and 67% respectively; tension-type headache 24%) were selected (mean age at clinic…

MalePediatricsmedicine.medical_specialtyAdolescentMigraine DisordersAdolescents; Children; Migraine; Primary headaches; Tension-type headache; Treatment; Pediatrics Perinatology and Child Health; Neurology (clinical)Tension-typeTriptansPizotifenPediatrics03 medical and health sciences0302 clinical medicinechildrenPrimary headacheBehavior TherapySurveys and QuestionnairesmedicineAcupunctureHumansAmitriptylinemigraine030212 general & internal medicineadolescentsPractice Patterns Physicians'ChildFlunarizineRetrospective Studiestreatmentbusiness.industryAnti-Inflammatory Agents Non-SteroidalGeneral Medicineadolescents; children; migraine; primary headaches; tension-type headache; treatmentPerinatology and Child Healthmedicine.diseasetension-type headacheMigraineTolerabilityItalyPediatrics Perinatology and Child HealthCohortAnticonvulsantsFemaleprimary headachesNeurology (clinical)businessheadache030217 neurology & neurosurgeryPrimary headaches; Migraine; Tension-type; headache; Treatment; Children; Adolescentsmedicine.drug
researchProduct

Relapse risk factors in anti-N-methyl-D-aspartate receptor encephalitis

2019

Aim: To identify factors that may predict and affect the risk of relapse in anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. Method: This was a retrospective study of an Italian cohort of patients with paediatric (≤18y) onset anti-NMDAR encephalitis. Results: Of the 62 children included (39 females; median age at onset 9y 10mo, range 1y 2mo–18y; onset between 2005 and 2018), 21 per cent relapsed (median two total events per relapsing patient, range 2–4). Time to first relapse was median 31.5 months (range 7–89mo). Severity at first relapse was lower than onset (median modified Rankin Scale [mRS] 3, range 2–4, vs median mRS 5, range 3–5; admission to intensive care unit: 0/10 vs 3/10…

Male030506 rehabilitationGastroenterologyCohort Studies0302 clinical medicineRetrospective StudieModified Rankin ScaleRecurrenceRisk FactorsChildrelapseAnti-N-Methyl-D-Aspartate Receptor EncephalitisHazard ratioItalyChild PreschoolCohortanti‐N‐methyl‐D‐aspartate receptor encephalitisFemale0305 other medical scienceEncephalitisHumanCohort studymedicine.medical_specialtyAdolescentSocio-culturaleanti-NMDAR antibodies03 medical and health sciencesanti-NMDARDevelopmental NeuroscienceInternal medicinemedicineAdolescent; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Child; Child Preschool; Cohort Studies; Female; Humans; Infant; Italy; Male; Recurrence; Retrospective Studies; Risk FactorsHumansPreschoolSurvival analysisRetrospective StudiesAutoimmune encephalitisbusiness.industryInfantRetrospective cohort studymedicine.diseaseanti-NMDAR antibodies autoimmune encephalitis anti‐N‐methyl‐D‐aspartate receptor encephalitisautoimmune encephalitisAnti-N-methyl-D-aspartate receptor encephalitis anti-NMDAR autoimmune encephalitis relapseAnti-N-Methyl-D-Aspartate Receptor EncephalitiPediatrics Perinatology and Child HealthNeurology (clinical)Cohort Studiebusiness030217 neurology & neurosurgery
researchProduct